Pharmacokinetics and Biomarker Analysis from a Phase 1/2 Open-Label Study of the Anti-Gpc3 T-cell Engager SAR444200, in Patients with Advanced Solid Tumors.

Maxime Chenard-Poirier,Khaldoun Almhanna,Darren Wan-Teck Lim,Anthony B. El-Khoueiry,Jens Samol,Baek-Yeol Ryoo,Jung Yong Hong,Robin Meng,Giovanni Abbadessa,Serena Masciari, Asma Kefsi,Yiding Zhang,Helene Guillemin-Paveau, Benoit Pasquier,Lucie Lepine,Ecaterina Elena Dumbrava

Journal of Clinical Oncology（2024）

引用 0|浏览5

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要